Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Protein degrading cancer drugs: The promises of the new generation

Bifunctional small molecules that mediate the degradation of extracellular proteins

Date

21 Oct 2023

Session

Protein degrading cancer drugs: The promises of the new generation

Topics

Cancer Biology;  Translational Research;  Targeted Therapy

Tumour Site

Presenters

David Spiegel

Authors

D. Spiegel

Author affiliations

  • Yale University School of Medicine - Yale Cancer Center, 06520 - New Haven/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion

Presenter: All Speakers

Session: Protein degrading cancer drugs: The promises of the new generation

Resources:

Slides

Webcast

Conclusions and perspectives

Presenter: David Spiegel

Session: Protein degrading cancer drugs: The promises of the new generation

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.